aid: capacity-bio
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/icons/capacity-bio.png
name: Capacity Bio
description: 'Capacity Bio is a clinical-stage biotechnology company developing mitophagy therapeutics
  to restore mitochondrial quality control in age- and disease-related conditions. Its platform advances
  small molecules, peptides, and nanoparticles that enhance identification and clearance of dysfunctional
  mitochondria. With operations in Los Angeles and Tokyo, the company closed a $35M financing round in
  2023 and is backed by Insight Partners. As a drug-development firm, Capacity Bio publishes no public
  API, developer platform, or SDK surface; this profile is maintained in the API Evangelist network as
  a company record.'
url: https://raw.githubusercontent.com/api-evangelist/capacity-bio/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- insight-partners
x-tier: stub
x-tier-reason: portfolio-lead
specificationVersion: '0.20'
created: '2026-07-17'
modified: '2026-07-18'
tags:
- Company
- Biotech Therapeutics
- Mitophagy
- Mitochondrial Biology
- Drug Development
- Therapeutics
- Biotechnology
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: Website
  url: https://capacitybio.com/
x-enrichment:
  date: '2026-07-19'
  status: backfilled
  pass: local-v1
  note: backfilled from .gitignore signal + verified work evidence